Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.
about
Endogenous cannabinoid signaling at inhibitory interneurons.Physiological basis for inhibition of morphine and improgan antinociception by CC12, a P450 epoxygenase inhibitor.Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibitionEndocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal greyInhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal grayEnhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model.Fast synaptic inhibition in spinal sensory processing and pain control.Dynamic regulation of the endocannabinoid system: implications for analgesia.No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.Cortical and subcortical modulation of pain.Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors.The Role of Cannabinoid Receptors in the Descending Modulation of Pain.Neural basis for improgan antinociception.Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons.WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
P2860
Q33624983-417D2FCB-86F2-4F75-9407-8A854ED4DDC7Q34430425-3CBD3D05-B25C-46AA-AA96-C78BDB6FA261Q34919623-1A47CCFC-95EF-4ED7-99C1-41012564BD7DQ34953319-5043530A-F385-47BD-80B4-3B3A1F85D189Q35130530-4320372E-F3AE-4B96-8AA9-50E533616D64Q35158147-858C6588-5666-4118-A8F5-B227E67F354DQ35286438-E4C6E760-660E-4176-A49C-781AFE32E16BQ36661675-5DE62CE7-3F2D-457B-BB58-18E96B349A9EQ37611106-511B72D5-2246-428F-8FAB-B3EC8E0F4B3DQ38185075-DF69B214-275C-40DA-8F6A-D53AEA8B5A13Q38777501-A127603A-3B6D-4605-88C0-D36436DDF880Q38874824-56D5460C-125C-4BE1-8803-EBE0D7C0B3FAQ38974429-125FAC30-6C05-4168-A0D5-9157B5325938Q42064514-1B5C9EA1-5BA6-4641-BA37-B2AC36393BA4Q42496848-64C6C0FF-658A-4835-96C2-6108AEF58270Q43075563-672EF5E8-2225-4E60-8D09-234D0B51741AQ47877991-12468AA6-C537-4F30-A118-8B9301B0DA76
P2860
Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Substance P drives endocannabi ...... descending analgesic pathway.
@en
Substance P drives endocannabi ...... descending analgesic pathway.
@nl
type
label
Substance P drives endocannabi ...... descending analgesic pathway.
@en
Substance P drives endocannabi ...... descending analgesic pathway.
@nl
prefLabel
Substance P drives endocannabi ...... descending analgesic pathway.
@en
Substance P drives endocannabi ...... descending analgesic pathway.
@nl
P1476
Substance P drives endocannabi ...... n descending analgesic pathway
@en
P2093
Geoffrey M Drew
P304
P356
10.1523/JNEUROSCI.4362-08.2009
P407
P577
2009-06-01T00:00:00Z